FeesSafety
Pluang+

Ethereum Foundation urges institutions to verify onchain data before decision-making for accountability.

Protocol Fundamentals
03 Nov 2026, 14:19 WIB
Tokenpost
View Source
Neutral
Ethereum Foundation urges institutions to verify onchain data before decision-making for accountability.

The Ethereum Foundation emphasized the importance of institutions verifying onchain blockchain data themselves before making decisions based on it. This approach aims to place accountability at the center of using blockchain information. Previously, the Foundation's evm.fast challenge developed execution proofs that allow validators to confirm block processing without having to rerun the entire process, enhancing efficiency and trust in data verification. This focus on data integrity and accountability could influence how institutions interact with blockchain technology going forward.

The Ethereum Foundation's call for institutions to verify onchain data is presented here with Pluang's market snapshot as of Nov 03, 2026 19:03 WIB: out of 50 major cryptocurrencies, 12 rose and 37 fell. Notable movers include BAT at Rp2.296 with a 1-day change of -4.09%, SAND at Rp803 down 3.47%, and AXS at Rp15.028 down 3.21%.

More News

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

Automatic FOUP Opener Market to reach $6.04B by 2032 with 5.36% CAGR driven by fab automation and contamination control

The global Automatic FOUP Opener Market is projected to grow from USD 4.41 billion in 2026 to USD 6.04 billion by 2032, expanding at a CAGR of 5.36%. Growth is driven by increasing fab automation, stricter contamination control requirements, and dema...

Market News
Bullish
19 minutes ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
3 hours ago
Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
3 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
3 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App